Microbial Cell Factories for the Production of Recombinant Human Interferon Gamma

dc.contributor.authorPandey, Rajat
dc.date.accessioned2016-08-31T07:35:36Z
dc.date.accessioned2023-10-19T11:06:16Z
dc.date.available2016-08-31T07:35:36Z
dc.date.available2023-10-19T11:06:16Z
dc.date.issued2016
dc.descriptionSupervisor: Veeranki Venkata Dasuen_US
dc.description.abstractIFN-γ is a dimerized, pleotropic cytokine and plays an important role in stimulating immune reactions. It is also critical for innate and adaptive immunity against viral and intracellular bacterial infections. With its already approved FDA status for the treatment of two diseases and excellent indications and positive results in the treatment of Tuberculosis and MDR-TB and other diseases, IFN-γ has the potential of becoming a lifesaver drug. IFN-γ as a drug is available in majority of developed/developing countries throughout the world; however it is not available in India. A cost effective method for the production of Recombinant Human IFN-γ can reduce the cost of treatment of chronic granulomatous disease and malignant osteopetrosis significantly which currently stands as $50000/year.en_US
dc.identifier.otherROLL NO. 10610609
dc.identifier.urihttps://gyan.iitg.ac.in/handle/123456789/735
dc.language.isoenen_US
dc.relation.ispartofseriesTH-1508;
dc.subjectBIOSCIENCES AND BIOENGINEERINGen_US
dc.titleMicrobial Cell Factories for the Production of Recombinant Human Interferon Gammaen_US
dc.typeThesisen_US
Files
Original bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
Abstract-TH-1508_10610609.pdf
Size:
143.17 KB
Format:
Adobe Portable Document Format
Description:
Abstract
No Thumbnail Available
Name:
TH-1508_10610609.pdf
Size:
37.21 MB
Format:
Adobe Portable Document Format
Description:
Thesis
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: